Xilio Therapeutics, Inc.
XLO
Revenue
2.36M
▲2.36M∞%
-Assets
89.87M
▲7.26M▲8.79%
3 Months ChangeLiabilities
56.46M
▼-387.00k▼-0.6808%
3 Months ChangeFree Cash Flow
-25.42M
▼-4.33M▼-20.54%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-13
Form 8-K
ID: 0001558370-24-012775
2024-08-08
Form 10-Q
ID: 0001558370-24-011471
2024-08-08
Form 8-K
ID: 0001558370-24-011470
2024-06-17
Form 8-K
ID: 0001558370-24-009247
2024-06-13
Form 8-K
ID: 0001558370-24-009138
2024-05-14
Form 10-Q
ID: 0001558370-24-008068
2024-05-14
Form 8-K
ID: 0001558370-24-008063
2024-04-01
Form 8-K
ID: 0001558370-24-004528
2024-03-28
Form 8-K
ID: 0001558370-24-004249
2024-03-28
Form 8-K
ID: 0001558370-24-004165